Literature DB >> 29887986

Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Charles H Jones1, Anders P Hakansson2,3, Blaine A Pfeifer1.   

Abstract

The development of safe and effective vaccines for the prevention of elusive infectious diseases remains a public health priority. Immunization, characterized by adaptive immune responses to specific antigens, can be raised by an array of delivery vectors. However, current commercial vaccination strategies are predicated on the retooling of archaic technology. This review will discuss current and emerging strategies designed to elicit immune responses in the context of genetic vaccination. Selected strategies at the biomaterial-biological interface will be emphasized to illustrate the potential of coupling both fields towards a common goal.

Entities:  

Year:  2014        PMID： 29887986      PMCID： PMC5990286          DOI： 10.1039/C4TB01058B

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN： 2050-750X            Impact factor:   6.331


  180 in total

1.  A brief history of polio vaccines.

Authors:  S Blume; I Geesink
Journal:  Science       Date:  2000-06-02       Impact factor: 47.728

2.  Bexsero: a multicomponent vaccine for prevention of meningococcal disease.

Authors:  Andrew R Gorringe; Rolando Pajón
Journal:  Hum Vaccin Immunother       Date:  2012-02-01       Impact factor: 3.452

3.  A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates.

Authors:  Dan H Barouch; Zhi-yong Yang; Wing-pui Kong; Birgit Korioth-Schmitz; Shawn M Sumida; Diana M Truitt; Michael G Kishko; Janelle C Arthur; Ayako Miura; John R Mascola; Norman L Letvin; Gary J Nabel
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 4.  The mechanism of action of MF59 - an innately attractive adjuvant formulation.

Authors:  D T O'Hagan; G S Ott; E De Gregorio; A Seubert
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

5.  Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules.

Authors:  J Fló; S Tisminetzky; F Baralle
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

6.  Wild-type intracellular bacteria deliver DNA into mammalian cells.

Authors:  Catherine Grillot-Courvalin; Sylvie Goussard; Patrice Courvalin
Journal:  Cell Microbiol       Date:  2002-03       Impact factor: 3.715

Review 7.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

8.  Direct transfer of cloned genes from bacteria to mammalian cells.

Authors:  W Schaffner
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

9.  A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy.

Authors:  Jan Peter van Pijkeren; David Morrissey; Ian R Monk; Michelle Cronin; Simon Rajendran; Gerald C O'Sullivan; Cormac G M Gahan; Mark Tangney
Journal:  Hum Gene Ther       Date:  2010-04       Impact factor: 5.695

10.  Construction and evaluation of V. cholerae O139 mutant, VCUSM21P, as a safe live attenuated cholera vaccine.

Authors:  Chandrika Murugaiah; Nik Zuraina Nik Mohd Noor; Shyamoli Mustafa; Ravichandran Manickam; Lalitha Pattabhiraman
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.